Skip to Content

Join the 'Prednicot' group to help and get support from people like you.

Prednicot Support Group

Further Information

Related Condition Support Groups

Inflammatory Conditions, Rheumatoid Arthritis, Adrenocortical Insufficiency, Acute Lymphocytic Leukemia, Allergic Reactions, Sinusitis, Fibromyalgia, Asthma, Idiopathic (Immune) Thrombocytopenic Purpura, view more... Ulcerative Colitis, Herpes Zoster Iridocyclitis, Immunosuppression, Skin Rash, Systemic Lupus Erythematosus, Multiple Sclerosis, Dermatitis Herpetiformis, Osteoarthritis, Cluster Headaches, Sarcoidosis, Nephrotic Syndrome, Inflammatory Bowel Disease, Psoriasis, Aspiration Pneumonia, Lymphoma, Mixed Connective Tissue Disease, Ankylosing Spondylitis, Leukemia, Contact Dermatitis, Atopic Dermatitis, Thrombocytopenia, Psoriatic Arthritis, Iridocyclitis, Gouty Arthritis, Polymyositis / Dermatomyositis, Seborrheic Dermatitis, Adrenogenital Syndrome, Uveitis (Posterior), Neurosarcoidosis, Bursitis, Conjunctivitis - Allergic, Dermatomyositis, Tuberculosis - Extrapulmonary, Lichen Planus, Autoimmune Hemolytic Anemia, Scleroderma, Pharyngitis, Herpes Zoster, Pemphigoid, Herpes Zoster Otitis Externa, Hypercalcemia of Malignancy, Cogan's Syndrome, Hay Fever, Allergic Rhinitis, Toxic Epidermal Necrolysis, Epicondylitis - Tennis Elbow, Mycosis Fungoides, Synovitis, Systemic Sclerosis, Tuberculous Meningitis, Iritis, Corneal Ulcer, Eczema, Chorioretinitis, Bullous Pemphigoid, Berylliosis, Erythroblastopenia, Graft-versus-host disease, Loeffler's Syndrome, Lichen Sclerosus, Keratitis, Juvenile Rheumatoid Arthritis, Pemphigus

Prednicot Patient Information at

Latest News

Imbruvica Approval Expanded to Include Graft Versus Host Disease

WEDNESDAY, Aug. 2, 2017 – The U.S. Food and Drug Administration on Wednesday expanded approval for the anti-cancer drug Imbruvica (ibrutinib) to include adults with chronic graft versus host disease ...

Read more news...

Ask a Question